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GASTRIC INTRAVASCULAR LYMPHOMA IN A DOG:  1 
CASE REPORT AND LITERATURE REVIEW 2 
 3 
Abstract 4 
Intravascular lymphoma (IVL) is a rare, high grade, extranodal lymphoma characterised by 5 
selective proliferation of neoplastic lymphocytes within the lumen of small vessels. A 10-6 
year-old, female intact mixed breed dog was presented with a 7-month history of vomiting 7 
and anorexia.  Physical examination revealed abdominal discomfort.  Ultrasonography and 8 
endoscopy identified a submucosal gastric mass.  Excision was performed by partial 9 
gastrectomy and histopathology and immunohistochemistry confirmed a T-cell IVL.  The 10 
owner declined chemotherapy, and the dog was instead treated palliatively with 11 
prednisolone.  Two months post-surgery, vomiting recurred and abdominal ultrasonography 12 
revealed a large gastric ulcer with focal peritonitis.  The dog was euthanised four months 13 
after initial presentation and post mortem examination confirmed IVL recurrence in the 14 
stomach and an isolated nodule of neoplastic cells in the omentum.  No involvement of 15 
other organs was found following histopathological examination.  This is the first description 16 




Gastric neoplasia accounts for less than 1 % of cancer in dogs, and carcinoma is the most 19 
common malignancy in this location.1,2  Other gastric tumours include leiomyoma, 20 
leiomyosarcoma, lymphoma, extramedullary plasmacytoma, mast cell tumour and 21 
histiocytic sarcoma.2  Gastrointestinal lymphoma is the most common form of extranodal 22 
lymphoma in dogs and involves the stomach in 16-40% of the cases.3,4  T-cell lymphomas are 23 
more prevalent and the disease is normally associated with a poor prognosis, with survival 24 
times ranging from 13 days to 14 weeks, due to a limited response to chemotherapy.4  25 
Intravascular lymphoma (IVL) is included in the canine WHO classification of lymphoid 26 
neoplasia as an uncommon, high grade, extranodal, subtype of lymphoma characterised by 27 
intravascular localisation of the neoplastic lymphocytes on histopathology.3,10 IVL has been 28 
reported in only 25 dogs, 2 cats and 1 horse.5-12,18 In the majority of cases, pronounced 29 
tropism for the central nervous system (CNS) results in progressive neurological deficits 30 
which are often multifocal.9-11  Given that there are difficulties in biopsying CNS lesions, the 31 
diagnosis is often made post mortem.  In all cases reported in dogs, IVL has been associated 32 
with an aggressive behaviour and a poor prognosis.5-12  To our knowledge, this is the first 33 
report of primary gastric IVL in a dog.34 
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Case history 35 
A 10-year-old, female intact mixed breed was presented with a 7-month history of vomiting, 36 
anorexia and intermittent signs of abdominal pain. Vomiting occurred daily, mainly after 37 
food ingestion.  Previous treatment included ranitidine (150mg per os q12h) and 38 
metoclopramide (10mg per os q8h) with only transient improvement of the clinical signs, 39 
and no response to feeding a low-fat highly digestible diet for 1 month.  On physical 40 
examination, the dog was underweight (body condition score [BCS]: 3/9, 10.2Kg) and 41 
discomfort was present during abdominal palpation, but no other abnormalities were 42 
detected. Haematology revealed moderate thrombocytosis (566 x109/L reference interval 43 
[RI]: 150-400).  Abnormalities in serum biochemistry included moderate hypoalbuminaemia 44 
(19.7g/L RI: 26.3-38.2), mild hyperglobulinaemia (44.6g/L RI: 23.4-42.2) with normal total 45 
protein concentration (64.3g/L RI: 54.9-75.3), mild hyperkalaemia (6.08mmol/L RI: 3.6-5.6), 46 
total hypocalcaemia (2.24mmol/L RI: 2.36-2.84) and hyperphosphataemia (1.71mmol/L RI: 47 
0.8-1.6). 48 
 49 
Thoracic radiographs were unremarkable, whereas abdominal radiographs revealed gastric 50 
wall thickening and mild small intestinal distention.  Ultrasonography confirmed a 51 
hypoechoic, thickened and irregular gastric wall with loss of layering in the fundic region 52 
(Figure 1).  Regional lymphadenopathy was noted, affecting the splenic (17x12mm), gastric 53 
(7x7mm) and hepatic (19x11mm) lymph nodes.  A hyperechoic nodule in the spleen 54 
(6x4mm) and another nodule in the liver (8x6mm) were also identified.  Cytological 55 
examination of fine-needle aspirates from general spleen, splenic lymph node, and gastric 56 
lymph node were all consistent with reactive lymphoid hyperplasia.  Gastroscopy confirmed 57 
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a large, rounded, irregular, submucosal mass in the lumen of the gastric fundus, between 58 
the angularis incisura and cardia (Figure 2). Multiple grab-biopsy samples were taken from 59 
both normal and abnormal gastric mucosa.  Pending results, the patient was discharged 60 
with maropitant (24mg per os q24h), omeprazole (10mg per os q24h), paracetamol (200mg 61 
per os q8h) and mirtazapine (15mg per os q24h). 62 
Histopathological examination of the gastric mass revealed a monomorphic proliferation of 63 
spindle cells which exhibited mild-to-moderate anisokaryosis.  Immunohistochemistry for 64 
pan-cytokeratin (pan-CK) and c-kit was negative, but neoplastic cells stained positively for 65 
alpha smooth muscle actin (α-SMA), suggesting a mesenchymal neoplasm, most likely a 66 
leiomyosarcoma.  Based on the staging undertaken, the lesion was thought potentially 67 
resectable and the dog underwent tumour excision via partial gastrectomy with 68 
approximately 2cm lateral margins excision.  The final histopathology report confirmed that 69 
below a large and deep chronic ulcer of the mucosa, there was a proliferation of atypical, 70 
large round cells (20 to 30μm in diameter) consistently located within the lumen of vessels 71 
throughout the submucosa and extending to the muscularis (Figure 3 a and b).  These cells 72 
exhibited moderate degree of cellular atypia, and mitotic index of 20 x 10 high power fields. 73 
Numerous acute and chronic thrombi, neoangiogenesis, oedema and vascular necrosis were 74 
associated with vascular occlusion. In co-localisation with the ulcer, vessels engorged with 75 
neoplastic round cells were also observed along the serosa and focally extending to the 76 
omentum.  The neoplastic round cells were positive for CD3 and negative for pan-77 
cytokeratin, Pax-5 and CD79α, confirming the diagnosis of T-cell intravascular lymphoma 78 




The patient´s clinical signs completely resolved after surgery.  Adjunctive chemotherapy 81 
options were declined by the owner due to financial constraints and the dog was continued 82 
on palliative treatment with prednisolone (10mg per os q24h) and omeprazole (10mg per os 83 
q24h). 84 
 85 
Two months after surgery, the dog returned to the hospital due to recurrence of vomiting.  86 
Ultrasonography revealed a large defect within the fundic stomach wall (19 x 25mm in 87 
diameter and 15mm depth) consistent with a gastric ulcer. There was marked thickening of 88 
the wall (up to 16mm) and loss of layering in both sides of the ulcer, indicating tumour 89 
recurrence.  The adjacent mesentery was hyperechoic and contained a small pocket of free 90 
fluid, suggesting focal peritonitis.  The nodular lesions in the liver and spleen and 91 
lymphadenopathy were similar to the previous study.  Due to the poor prognosis associated 92 
with this subtype of lymphoma, the early recurrence and the risk of imminent stomach 93 
perforation the dog was euthanised four months after diagnosis. 94 
 95 
Post mortem examination of the stomach confirmed the presence of recurrent masses 96 
within the gastric wall associated with large mucosal ulcerations (Figure 3 e and f).  97 
Microscopically, the presence of neoplastic cells within the vascular lumina was associated 98 
with occlusive thrombi and consequent ischemic lesions and endothelial damage.  A single 99 
extra-gastric focus of intravascular lymphoma was detected in the omentum, close the 100 
serosa of the stomach.  Given that the post-surgical histopathology examination reported 101 
extension of the neoplastic cells to the omentum, this omental nodule likely reflected 102 
residual disease due to incomplete excision.  Histopathological examination of the thyroid, 103 
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adrenal glands, brain, heart, lungs, liver, spleen, bone marrow, tonsils, pancreatic and 104 
gastric lymph nodes, pancreas, small intestine, colon, kidneys, urinary bladder, ovaries and 105 
peripheral nervous tissue (including both sciatic nerves and brachial plexuses) showed no 106 
evidence of IVL.107 
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Discussion and literature review 108 
Intravascular lymphoma is a rare, high grade, extranodal lymphoma characterised by 109 
monoclonal proliferation of lymphocytes within the lumen of vessels.3,10  The diagnosis of 110 
IVL is challenging due to the non-specific clinical signs, the absence of peripheral 111 
lymphadenopathy and the fact that neoplastic cells are rarely found in the peripheral 112 
blood.6 The mechanism by which these tumours arise and why neoplastic lymphocytes 113 
remain confined to the local vascular lumina remains uncertain.13,18  Some authors suggest 114 
that the presence of vascular microthrombi could cause occlusion of the vessels and limit 115 
the dissemination of neoplastic cells within the vasculature,13 but this theory is unlikely 116 
given that most dogs die with disseminated disease.  More recently, abnormalities in the 117 
molecules involved in lymphocyte and endothelial adhesion has been speculated due to the 118 
lack of β1 and β2 integrins in some human IVL, both which are essential for transvascular 119 
migration.10  A recent study showed that canine IVL strongly expressed CD44 and, more 120 
inconsistently CD29, suggesting cell surface adhesion receptors could play a role in the 121 
formation of lymphocyte aggregates.18 122 
 123 
In contrast to humans, where IVL is classified as a non-Hodgkin's, diffuse large B-cell 124 
lymphoma in 90% of cases, in dogs it seems to have a predominant T-cell 125 
immunophenotype, with null cell phenotypes being more common that B-cell phenotypes.10  126 
However, this has been recently questioned in a small case series where both B and T cell 127 
immunophenotype were found to be equally prevalent.18 Immunopositivity for CD3 in this 128 




Neurological signs, including ataxia, paresis and vestibular deficits, are reported in up to 131 
88% of dogs with IVL.10  Despite the tropism of this tumour for nervous tissue, no 132 
neurological signs were reported in this patient and histopathological examination of the 133 
brain, spinal cord and peripheral nerves at post mortem revealed no neoplastic cells.  In 134 
humans, other common clinical signs include skin lesions (erythema and eruptions), fatigue 135 
or pyrexia of unknown origin, but these seem to be rare in animals.15  Vomiting, 136 
haematochezia and melena are uncommonly reported in humans.16-17 137 
 138 
Clinico-pathological findings in cases of IVL are normally non-specific but may reflect organ 139 
involvement.  The thrombocytosis seen in this case could reflect intermittent 140 
gastrointestinal bleeding from the tumour or stress-related increase in endogenous steroids 141 
due to chronic vomiting.  Hypoalbuminemia occurs as a consequence of neoplastic 142 
infiltration causing gastric barrier disruption.  This abnormality was found in 80% of dogs 143 
with gastrointestinal lymphoma and is a negative prognostic factor for these patients.2,3  The 144 
ultrasonographic findings in dogs with gastrointestinal lymphoma can vary widely and 145 
include irregularities in the mucosal surface, changes in wall thickness and layering, variable 146 
echogenicity and presence of regional lymphadenopathy, but no pathognomonic sign 147 
exists.20  Interestingly, one study identified lymphoma as the most common gastric 148 
neoplasia missed on ultrasonography.20 149 
 150 
Given these limitations, endoscopy is the preferred non-invasive method to obtain a 151 
diagnosis.  In this case, the endoscopic appearance of the tumour differs from the ones 152 
reported in humans, where polypoid lesions predominate.16,17  The misdiagnosis of 153 
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leiomyosarcoma on the endoscopical biopsies likely reflects non-representative sampling of 154 
highly-reactive spindloid myofibroblasts and fibroblasts attempting to heal the superificial 155 
portion of the ulcerated mucosa, while the primary population of neoplastic cells was 156 
“hidden” deep within the submucosa and muscularis.  The limitations associated with 157 
endocopically-guided biopsies are well known:4 in one study, endoscopically-guided biopsies 158 
in dogs and cats with gastrointestinal lymphoma produced accurate results in only 59% of 159 
the cases.20 160 
 161 
In the majority of dogs reported to have IVL, diagnosis was achieved at post mortem 162 
examination.  Only two cases have been described where an ante mortem diagnosis was 163 
made in dogs that underwent skin and brain biopsies, respectively.9,14 Unlike the current 164 
case, all previously reported dogs with IVL undergoing full post mortem examinations have 165 
been found to have widespread dissemination of the tumour.5-12 166 
 167 
The difficulty in obtaining a prompt diagnosis, the rarity of the disease and the rapid 168 
progression of IVL can make appropriate invervention very difficult.15  The only two dogs 169 
where diagnosis was achieved ante mortem deteriorated within 2 and 4 weeks due to 170 
cancer progression.9,14 The dog in this case report survived 4 months, which likely reflects 171 
the localised presentation and the lack of central nervous system involvement in our 172 
patient.  Surgical debulking of the local disease likely extended survival.  Unfortunately, 173 




In the current case, the owners declined post-operative chemotherapy.  There is only one 176 
case report of a dog with intracranial IVL treated with chemotherapy (L-asparaginase and 177 
vincristine), and no clinical response was observed.9  In humans, chemotherapy with CHOP 178 
(vincristine, cyclophosphamide and doxorubicin) is reasonably effective with complete 179 
responses in 55% of the cases, with some patients achieving prolonged periods of disease-180 
free survivals.15  The addition of rituximab, high-dose methotrexate and cytarabine in cases 181 
with central nervous involvement provides clinical benefit, with disease free intervals 182 
ranging from 14 months to 2 years.19  The role of radiotherapy in the management of IVL is 183 
still poorly defined but could help with tumour control in localised cases.19 184 
 185 
The formation of microthrombi within the tumour, as it was seen in the histopathology of 186 
our dog, may contribute to tissue hypoxia and play a role in chemoresistance by difficulting 187 
chemotherapy drug penetration within the tumour.23  The presence of fibrin thombi is 188 
commonly described in the histopathology findings from humans with IVL and recent 189 
studies have suggested a potential benefit in treating these patients concurrently with 190 
unfractionated heparin based on the potential expression of heparin-responsive adhesion 191 
molecules, such as L-selectin, in neoplastic lymphocytes responsible for IVL.21-23  192 
Additionally, unfractionated heparin has been shown to inhibit p-glycoprotein-mediated 193 
multidrug resistance in vitro and improves survival in cancer patients with a pro-thrombotic 194 
state. Thus, treatment with heparin could prevent the aggregation of the neoplastic 195 
lymphocytes within vascular lumen, thereby reducing the formation of microthrombi within 196 




Despite the available treatments, human IVL is associated with a mortality rate of 80%.15  199 
This reflects the need for development of a diagnostic algorithm and serum biomarkers to 200 




Intravascular lymphoma should be considered as a rare differential for gastric tumours. The 203 
localised presentation and the lack of central nervous system involvement could be 204 
associated with longer survivals as demonstrated in the current case.  IVL should still be 205 
approached as a systemic disease and a poor prognosis should be expected, particularly in 206 
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FIGURE. 1. Ultrasonographic image of the stomach of a 10-year-old, female intact mixed 272 
breed dog with gastric intravascular lymphoma:  the gastric wall in the fundic region is 273 
focally thickened (21.6mm in maximum diameter) and hypoechoic with loss of layering 274 
(arrow) compared to the rest of the stomach (arrowhead).  275 
 276 
FIGURE. 2. Gastroscopy images of the stomach of a 10-year-old, female entire mixed breed 277 
dog with intravascular lymphoma. A large, ulcerated submucosal mass was found in the 278 
pyloric region of the stomach. 279 
 280 
FIGURE. 3. Gross and histopathological findings of intravascular lymphoma in the stomach 281 
of a 10-year-old, female entire mixed breed dog. A. Submucosa and muscularis are almost 282 
completely composed of numerous vessels engorged by large atypical round cells and 283 
occluding thrombi (100X, scale bar 200μm). B. Monomorphic population of round atypical 284 
cells, among which some are in mitosis, occupy the vascular lumina (400X, scale bar 25μm). 285 
C. The majority of intravascular atypical round cells are CD3 positive (200X, scale bar 50μm). 286 
D. CD79a positive cells are scattered within the interstitium (200X, scale bar 50μm). E. Post-287 
mortem image of the stomach showing one of two large foci of mucosal thickening with 288 
central large depressed ulcer. F. Post-mortem examination of the stomach. On cut surface, 289 
wall thickness is increased and layers obscured by the ulcerated mass.   290 
 291 
